{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:35:07Z","timestamp":1740123307593,"version":"3.37.3"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10792-020-01634-8","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T07:02:39Z","timestamp":1605164559000},"page":"1103-1109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential neuroprotective biomolecules in ophthalmology"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2348-9163","authenticated-orcid":false,"given":"Mehrdad","family":"Afarid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9508-2632","authenticated-orcid":false,"given":"Fatemeh","family":"Sanie-Jahromi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"1634_CR1","volume-title":"Global initiative for the elimination of avoidable blindness: action plan 2006\u20132011","author":"World Health Organization","year":"2007","unstructured":"World Health Organization (2007) Global initiative for the elimination of avoidable blindness: action plan 2006\u20132011. World Health Organization, Geneva"},{"issue":"7","key":"1634_CR2","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/bjo.86.7.716","volume":"86","author":"I Kocur","year":"2002","unstructured":"Kocur I, Resnikoff S (2002) Visual impairment and blindness in Europe and their prevention. Br J Ophthalmol 86(7):716\u2013722","journal-title":"Br J Ophthalmol"},{"key":"1634_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.preteyeres.2018.02.002","volume":"65","author":"MT Pardue","year":"2018","unstructured":"Pardue MT, Allen RS (2018) Neuroprotective strategies for retinal disease. Prog Retinal Eye Res 65:50\u201376","journal-title":"Prog Retinal Eye Res"},{"issue":"3","key":"1634_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/ICU.0000000000000558","volume":"30","author":"TJ Wubben","year":"2019","unstructured":"Wubben TJ, Zacks DN, Besirli CG (2019) Retinal neuroprotection: current strategies and future directions. Curr Opin Ophthalmol 30(3):199\u2013205","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"1634_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/02713683.2017.1396617","volume":"43","author":"AA Shpak","year":"2018","unstructured":"Shpak AA, Guekht AB, Druzhkova TA, Kozlova KI, Gulyaeva NV (2018) Brain-derived neurotrophic factor in patients with primary open-angle glaucoma and age-related cataract. Curr Eye Res 43(2):224\u2013231","journal-title":"Curr Eye Res"},{"issue":"10","key":"1634_CR6","doi-asserted-by":"publisher","first-page":"e907-e","DOI":"10.1038\/tp.2016.186","volume":"6","author":"S Jiao","year":"2016","unstructured":"Jiao S, Shen L, Zhu C, Bu X, Liu Y, Liu C et al (2016) Brain-derived neurotrophic factor protects against taurelated neurodegeneration of Alzheimer\u2019s disease. Transl Psychiatry 6(10):e907-e","journal-title":"Transl Psychiatry"},{"issue":"1","key":"1634_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1167\/iovs.09-3740","volume":"51","author":"AJ Weber","year":"2010","unstructured":"Weber AJ, Viswan\u00e1than S, Ramanathan C, Harman CD (2010) Combined application of BDNF to the eye and brain enhances ganglion cell survival and function in the cat after optic nerve injury. Invest Ophthalmol Vis Sci 51(1):327\u2013334","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1634_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/IAE.0000000000002355","volume":"40","author":"AGT Uzel","year":"2020","unstructured":"Uzel AGT, Ugurlu N, Toklu Y, \u00c7I\u00e7ek M, Boral B, Sener B et al (2020) Relationship between stages of diabetic retinopathy and levels of brain-derived neurotrophic factor in aqueous humor and serum. Retina 40(1):121\u20135","journal-title":"Retina"},{"issue":"6","key":"1634_CR9","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3892\/mmr.2013.1433","volume":"7","author":"Y Liu","year":"2013","unstructured":"Liu Y, Tao L, Fu X, Zhao Y, Xu X (2013) BDNF protects retinal neurons from hyperglycemia through the TrkB\/ERK\/MAPK pathway. Mol Med Rep 7(6):1773\u20131778","journal-title":"Mol Med Rep"},{"issue":"3","key":"1634_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10571-012-9901-8","volume":"33","author":"MS Ola","year":"2013","unstructured":"Ola MS, Nawaz MI, El-Asrar AA, Abouammoh M, Alhomida AS (2013) Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats. Cell Mol Neurobiol 33(3):359\u2013367","journal-title":"Cell Mol Neurobiol"},{"key":"1634_CR11","first-page":"1","volume":"2020","author":"M Afarid","year":"2020","unstructured":"Afarid M, Namvar E, Sanie-Jahromi F (2020) Diabetic retinopathy and BDNF: a review on its molecular basis and clinical applications. J Ophthalmol 2020:1\u20137","journal-title":"J Ophthalmol"},{"key":"1634_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jns.2016.02.024","volume":"363","author":"M Afarid","year":"2016","unstructured":"Afarid M, Torabi-Nami M, Zare B (2016) Neuroprotective and restorative effects of the brain-derived neurotrophic factor in retinal diseases. J Neurol Sci 363:43\u201350","journal-title":"J Neurol Sci"},{"issue":"5","key":"1634_CR13","first-page":"991","volume":"8","author":"M Afarid","year":"2015","unstructured":"Afarid M, Torabi-Nami M, Nemati A, Khosravi A, Malekzadeh M (2015) Brain-derived neurotrophic factor in patients with advanced age-related macular degeneration. Int J ophthalmol 8(5):991","journal-title":"Int J ophthalmol"},{"issue":"9","key":"1634_CR14","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.2337\/diabetes.53.9.2412","volume":"53","author":"M Seki","year":"2004","unstructured":"Seki M, Tanaka T, Nawa H, Usui T, Fukuchi T, Ikeda K et al (2004) Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 53(9):2412\u20132419","journal-title":"Diabetes"},{"issue":"10","key":"1634_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-1041-8","volume":"9","author":"A Osborne","year":"2018","unstructured":"Osborne A, Khatib TZ, Songra L, Barber AC, Hall K, Kong GY et al (2018) Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor\/tropomyosin-related kinase receptor-B signaling. Cell Death Dis 9(10):1\u201318","journal-title":"Cell Death Dis"},{"issue":"2","key":"1634_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0304-3940(01)01830-4","volume":"305","author":"M-L Ko","year":"2001","unstructured":"Ko M-L, Hu D-N, Ritch R, Sharma S, Chen C-F (2001) Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats. Neurosci Lett 305(2):139\u2013142","journal-title":"Neurosci Lett"},{"issue":"12","key":"1634_CR17","doi-asserted-by":"publisher","first-page":"e115579","DOI":"10.1371\/journal.pone.0115579","volume":"9","author":"L Domenici","year":"2014","unstructured":"Domenici L, Origlia N, Falsini B, Cerri E, Barloscio D, Fabiani C et al (2014) Rescue of retinal function by BDNF in a mouse model of glaucoma. PloS one 9(12):e115579","journal-title":"PloS one"},{"issue":"5","key":"1634_CR18","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1097\/00001756-200104170-00043","volume":"12","author":"T Shuto","year":"2001","unstructured":"Shuto T, Horie H, Hikawa N, Sango K, Tokashiki A, Murata H et al (2001) IL-6 up-regulates CNTF mRNA expression and enhances neurite regeneration. NeuroReport 12(5):1081\u20131085","journal-title":"NeuroReport"},{"issue":"1","key":"1634_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1083\/jcb.118.1.139","volume":"118","author":"M Sendtner","year":"1992","unstructured":"Sendtner M, St\u00f6ckli K, Thoenen H (1992) Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration. J Cell Biol 118(1):139\u2013148","journal-title":"J Cell Biol"},{"issue":"2","key":"1634_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/00001756-199902050-00038","volume":"10","author":"W-K Ju","year":"1999","unstructured":"Ju W-K, Lee M-Y, Hofmann H-D, Kirsch M, Chun M-H (1999) Expression of CNTF in M\u00fcller cells of the rat retina after pressure-induced ischemia. NeuroReport 10(2):419\u2013422","journal-title":"NeuroReport"},{"issue":"9","key":"1634_CR21","doi-asserted-by":"publisher","first-page":"e23148","DOI":"10.1371\/journal.pone.0023148","volume":"6","author":"R Li","year":"2011","unstructured":"Li R, Wen R, Banzon T, Maminishkis A, Miller SS (2011) CNTF mediates neurotrophic factor secretion and fluid absorption in human retinal pigment epithelium. PloS one 6(9):e23148","journal-title":"PloS one"},{"key":"1634_CR22","first-page":"232","volume":"11","author":"W Beltran","year":"2005","unstructured":"Beltran W, Rohrer H, Aguirre GD (2005) Immunolocalization of ciliary neurotrophic factor receptor \u03b1 (CNTFR\u03b1) in mammalian photoreceptor cells. Mole Vis 11:232","journal-title":"Mole Vis"},{"issue":"3","key":"1634_CR23","first-page":"927","volume":"41","author":"KJ Wahlin","year":"2000","unstructured":"Wahlin KJ, Campochiaro PA, Zack DJ, Adler R (2000) Neurotrophic factors cause activation of intracellular signaling pathways in Muller cells and other cells of the inner retina, but not photoreceptors. Invest Ophthalmol Vis Sci 41(3):927\u2013936","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1634_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/(SICI)1096-9861(19981019)400:2<244::AID-CNE6>3.0.CO;2-9","volume":"400","author":"S Fuhrmann","year":"1998","unstructured":"Fuhrmann S, Kirsch M, Heller S, Rohrer H, Hofmann HD (1998) Differential regulation of ciliary neurotrophic factor receptor-\u03b1 expression in all major neuronal cell classes during development of the chick retina. J Comp Neurol 400(2):244\u2013254","journal-title":"J Comp Neurol"},{"issue":"2","key":"1634_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0006-8993(03)03130-5","volume":"985","author":"K Valter","year":"2003","unstructured":"Valter K, Bisti S, Stone J (2003) Location of CNTFR\u03b1 on outer segments: evidence of the site of action of CNTF in rat retina. Brain Res 985(2):169\u2013175","journal-title":"Brain Res"},{"issue":"2","key":"1634_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1167\/iovs.03-0182","volume":"45","author":"V Seydewitz","year":"2004","unstructured":"Seydewitz V, Rothermel A, Fuhrmann S, Schneider A, DeGrip WJ, Layer PG et al (2004) Expression of CNTF receptor-\u03b1 in chick violet-sensitive cones with unique morphologic properties. Invest Ophthalmol Vis Sci 45(2):655\u2013661","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1634_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/neu.20117","volume":"63","author":"B Van Adel","year":"2005","unstructured":"Van Adel B, Arnold J, Phipps J, Doering L, Ball A (2005) Ciliary neurotrophic factor protects retinal ganglion cells from axotomy-induced apoptosis via modulation of retinal glia in vivo. J Neurobiol 63(3):215\u2013234","journal-title":"J Neurobiol"},{"issue":"52","key":"1634_CR28","doi-asserted-by":"publisher","first-page":"13523","DOI":"10.1523\/JNEUROSCI.4021-06.2006","volume":"26","author":"R Wen","year":"2006","unstructured":"Wen R, Song Y, Kjellstrom S, Tanikawa A, Liu Y, Li Y et al (2006) Regulation of rod phototransduction machinery by ciliary neurotrophic factor. J Neurosci 26(52):13523\u201313530","journal-title":"J Neurosci"},{"issue":"3","key":"1634_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1006\/nbdi.2000.0285","volume":"7","author":"J Weise","year":"2000","unstructured":"Weise J, Isenmann S, Kl\u00f6cker N, K\u00fcgler S, Hirsch S, Gravel C et al (2000) Adenovirus-mediated expression of ciliary neurotrophic factor (CNTF) rescues axotomized rat retinal ganglion cells but does not support axonal regeneration in vivo. Neurobiol Dis 7(3):212\u2013223","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1634_CR30","doi-asserted-by":"publisher","first-page":"e9495","DOI":"10.1371\/journal.pone.0009495","volume":"5","author":"Y Li","year":"2010","unstructured":"Li Y, Tao W, Luo L, Huang D, Kauper K, Stabila P et al (2010) CNTF induces regeneration of cone outer segments in a rat model of retinal degeneration. PloS one 5(3):e9495","journal-title":"PloS one"},{"issue":"2","key":"1634_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0306-4522(98)00546-6","volume":"89","author":"S Jo","year":"1999","unstructured":"Jo S, Wang E, Benowitz L (1999) Ciliary neurotrophic factor is an axogenesis factor for retinal ganglion cells. Neuroscience 89(2):579\u2013591","journal-title":"Neuroscience"},{"issue":"45","key":"1634_CR32","doi-asserted-by":"publisher","first-page":"14334","DOI":"10.1523\/JNEUROSCI.2770-09.2009","volume":"29","author":"M Leibinger","year":"2009","unstructured":"Leibinger M, M\u00fcller A, Andreadaki A, Hauk TG, Kirsch M, Fischer D (2009) Neuroprotective and axon growth-promoting effects following inflammatory stimulation on mature retinal ganglion cells in mice depend on ciliary neurotrophic factor and leukemia inhibitory factor. J Neurosci 29(45):14334\u201314341","journal-title":"J Neurosci"},{"issue":"3","key":"1634_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.22336\/rjo.2017.29","volume":"61","author":"C Iulia","year":"2017","unstructured":"Iulia C, Ruxandra T, Costin L-B, Liliana-Mary V (2017) Citicoline\u2014a neuroprotector with proven effects on glaucomatous disease. Romanian J ophthalmol 61(3):152","journal-title":"Romanian J ophthalmol"},{"key":"1634_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12974\/2309-6136.2015.03.01.1","volume":"3","author":"G Zerbini","year":"2015","unstructured":"Zerbini G, Bandello F, Lattanzio R, Gabellini D, Zucchiatti I, Spinello A et al (2015) In vivo evaluation of retinal and choroidal structure in a mouse model of long-lasting diabetes. Effect of topical treatment with citicoline. J Ocul Dis Ther 3:1\u20138","journal-title":"J Ocul Dis Ther"},{"issue":"3","key":"1634_CR35","first-page":"PI24","volume":"9","author":"R Rejdak","year":"2003","unstructured":"Rejdak R, Toczo\u0142owski J, Kurkowski J, Kami\u0144ski M, Rejdak K, Stelmasiak Z et al (2003) Oral citicoline treatment improves visual pathway function in glaucoma. Med Sci Monit 9(3):PI24\u2013PI8","journal-title":"Med Sci Monit"},{"issue":"3","key":"1634_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000063658","volume":"34","author":"R Rejdak","year":"2002","unstructured":"Rejdak R, Toczo\u0142owski J, Solski J, Duma D, Grieb P (2002) Citicoline treatment increases retinal dopamine content in rabbits. Ophthalmic Res 34(3):146\u2013149","journal-title":"Ophthalmic Res"},{"issue":"5","key":"1634_CR37","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.exer.2006.05.021","volume":"83","author":"F Schuettauf","year":"2006","unstructured":"Schuettauf F, Rejdak R, Thaler S, Bolz S, Lehaci C, Mankowska A et al (2006) Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat. Exp Eye Res 83(5):1128\u20131134","journal-title":"Exp Eye Res"},{"issue":"3","key":"1634_CR38","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.exer.2005.02.007","volume":"81","author":"CH Park","year":"2005","unstructured":"Park CH, Kim YS, Noh HS, Cheon EW, Yang YA, Yoo JM et al (2005) Neuroprotective effect of citicoline against KA-induced neurotoxicity in the rat retina. Exp Eye Res 81(3):350\u2013358","journal-title":"Exp Eye Res"},{"issue":"6","key":"1634_CR39","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S0161-6420(99)90269-5","volume":"106","author":"V Parisi","year":"1999","unstructured":"Parisi V, Manni G, Colacino G, Bucci MG (1999) Cytidine-5\u2032-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma. Ophthalmology 106(6):1126\u20131134","journal-title":"Ophthalmology"},{"issue":"1","key":"1634_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10633-005-7348-7","volume":"110","author":"V Parisi","year":"2005","unstructured":"Parisi V (2005) Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5\u2032-diphosphocholine (citicoline): a study of 8 years of follow-up. Doc Ophthalmol 110(1):91\u2013102","journal-title":"Doc Ophthalmol"},{"key":"1634_CR41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0079-6123(08)01137-0","volume":"173","author":"V Parisi","year":"2008","unstructured":"Parisi V, Coppola G, Centofanti M, Oddone F, Angrisani AM, Ziccardi L et al (2008) Evidence of the neuroprotective role of citicoline in glaucoma patients. Prog Brain Res 173:541\u2013554","journal-title":"Prog Brain Res"},{"issue":"3","key":"1634_CR42","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1212\/WNL.50.3.701","volume":"50","author":"K Johnson","year":"1998","unstructured":"Johnson K, Brooks B, Cohen J, Ford C, Goldstein J, Lisak R et al (1998) Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Neurology 50(3):701\u2013708","journal-title":"Neurology"},{"issue":"7","key":"1634_CR43","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1212\/WNL.45.7.1268","volume":"45","author":"K Johnson","year":"1995","unstructured":"Johnson K, Brooks B, Cohen J, Ford C, Goldstein J, Lisak R et al (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 45(7):1268\u20131276","journal-title":"Neurology"},{"issue":"2","key":"1634_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0163-7258(03)00036-6","volume":"98","author":"S Dhib-Jalbut","year":"2003","unstructured":"Dhib-Jalbut S (2003) Glatiramer acetate (Copaxone\u00ae) therapy for multiple sclerosis. Pharmacol Ther 98(2):245\u2013255","journal-title":"Pharmacol Ther"},{"issue":"8","key":"1634_CR45","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1167\/iovs.03-0080","volume":"44","author":"S Bakalash","year":"2003","unstructured":"Bakalash S, Kessler A, Mizrahi T, Nussenblatt R, Schwartz M (2003) Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma. Invest Ophthalmol Vis Sci 44(8):3374\u20133381","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"1634_CR46","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1073\/pnas.041609498","volume":"98","author":"H Schori","year":"2001","unstructured":"Schori H, Kipnis J, Yoles E, WoldeMussie E, Ruiz G, Wheeler LA et al (2001) Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci 98(6):3398\u20133403","journal-title":"Proc Natl Acad Sci"},{"issue":"13","key":"1634_CR47","doi-asserted-by":"publisher","first-page":"7446","DOI":"10.1073\/pnas.97.13.7446","volume":"97","author":"J Kipnis","year":"2000","unstructured":"Kipnis J, Yoles E, Porat Z, Cohen A, Mor F, Sela M et al (2000) T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci 97(13):7446\u20137451","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"1634_CR48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1089\/jop.2010.0145","volume":"27","author":"M Abrishami","year":"2011","unstructured":"Abrishami M, Khalifeh M, Shoayb M, Abrishami M (2011) Therapeutic effects of high-dose intravenous prednisolone in methanol-induced toxic optic neuropathy. J Ocul Pharmacol Ther 27(3):261\u2013263","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"1634_CR49","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1471-4159.2011.07354.x","volume":"118","author":"F Doonan","year":"2011","unstructured":"Doonan F, O\u2019Driscoll C, Kenna P, Cotter TG (2011) Enhancing survival of photoreceptor cells in vivo using the synthetic progestin Norgestrel. J Neurochem 118(5):915\u2013927","journal-title":"J Neurochem"},{"issue":"1","key":"1634_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000301245","volume":"124","author":"R Posthumus","year":"1952","unstructured":"Posthumus R (1952) The use and the possibilities of progesterone in the treatment of glaucoma. Ophthalmologica 124(1):17\u201325","journal-title":"Ophthalmologica"},{"issue":"1","key":"1634_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0002-9394(99)00076-8","volume":"128","author":"CB Toris","year":"1999","unstructured":"Toris CB, Camras CB, Yablonski ME (1999) Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. Am J Ophthalmol 128(1):8\u201314","journal-title":"Am J Ophthalmol"},{"key":"1634_CR52","first-page":"117","volume":"3","author":"A Galanopoulos","year":"2009","unstructured":"Galanopoulos A, Goldberg I (2009) Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension. Clin ophthalmol (Auckl NZ) 3:117","journal-title":"Clin ophthalmol (Auckl NZ)"},{"key":"1634_CR53","doi-asserted-by":"publisher","first-page":"S290","DOI":"10.1016\/S0039-6257(01)00206-5","volume":"45","author":"LA Wheeler","year":"2001","unstructured":"Wheeler LA, Gil DW, WoldeMussie E (2001) Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma. Surv Ophthalmol 45:S290\u2013S294","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"1634_CR54","first-page":"2299","volume":"40","author":"DB Bylund","year":"1999","unstructured":"Bylund DB, Chacko DM (1999) Characterization of \u03b12 adrenergic receptor subtypes in human ocular tissue homogenates. Invest Ophthalmol Vis Sci 40(10):2299\u20132306","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"(1_suppl)","key":"1634_CR55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/112067219900901S09","volume":"9","author":"L Wheeler","year":"1999","unstructured":"Wheeler L, Lai R, Woldemussie E (1999) From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury. Eur J Ophthalmol 9((1_suppl)):17\u201321","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"1634_CR56","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40618-014-0096-3","volume":"37","author":"H Hosseinzadeh","year":"2014","unstructured":"Hosseinzadeh H, Nassiri-Asl M (2014) Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid. J Endocrinol Invest 37(9):783\u2013788","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"1634_CR57","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s11095-005-6250-z","volume":"22","author":"H Kim","year":"2005","unstructured":"Kim H, Kong H, Choi B, Yang Y, Kim Y, Lim MJ et al (2005) Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharm Res 22(9):1499\u20131509","journal-title":"Pharm Res"},{"issue":"3","key":"1634_CR58","first-page":"e81","volume":"161","author":"N Pescosolido","year":"2010","unstructured":"Pescosolido N, Librando A (2010) Oral administration of an association of forskolin, rutin and vitamins B1 and B2 potentiates the hypotonising effects of pharmacological treatments in POAG patients. La Clinica terapeutica 161(3):e81\u2013e85","journal-title":"La Clinica terapeutica"},{"issue":"5","key":"1634_CR59","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1089\/jop.2012.0021","volume":"28","author":"M Vetrugno","year":"2012","unstructured":"Vetrugno M, Uva MG, Russo V, Iester M, Ciancaglini M, Brusini P et al (2012) Oral administration of forskolin and rutin contributes to intraocular pressure control in primary open angle glaucoma patients under maximum tolerated medical therapy. J Ocul Pharmacol Ther 28(5):536\u2013541","journal-title":"J Ocul Pharmacol Ther"},{"key":"1634_CR60","first-page":"1784","volume":"17","author":"M Nakayama","year":"2011","unstructured":"Nakayama M, Aihara M, Chen Y-N, Araie M, Tomita-Yokotani K, Iwashina T (2011) Neuroprotective effects of flavonoids on hypoxia-, glutamate-, and oxidative stress\u2013induced retinal ganglion cell death. Mol Vision 17:1784","journal-title":"Mol Vision"},{"issue":"7","key":"1634_CR61","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10571-014-0084-3","volume":"34","author":"J-Y Na","year":"2014","unstructured":"Na J-Y, Kim S, Song K, Kwon J (2014) Rutin alleviates prion peptide-induced cell death through inhibiting apoptotic pathway activation in dopaminergic neuronal cells. Cell Mol Neurobiol 34(7):1071\u20131079","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"1634_CR62","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s12031-015-0561-2","volume":"56","author":"MS Ola","year":"2015","unstructured":"Ola MS, Ahmed MM, Ahmad R, Abuohashish HM, Al-Rejaie SS, Alhomida AS (2015) Neuroprotective effects of rutin in streptozotocin-induced diabetic rat retina. J Mol Neurosci 56(2):440\u2013448","journal-title":"J Mol Neurosci"},{"key":"1634_CR63","first-page":"1","volume":"2017","author":"D Rusciano","year":"2017","unstructured":"Rusciano D, Pezzino S, Mutolo MG, Giannotti R, Librando A, Pescosolido N (2017) Neuroprotection in glaucoma: old and new promising treatments. Adv Pharmacol Sci 2017:1\u201319","journal-title":"Adv Pharmacol Sci"},{"issue":"3","key":"1634_CR64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1474-9726.2007.00295.x","volume":"6","author":"O Thibault","year":"2007","unstructured":"Thibault O, Gant JC, Landfield PW (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer\u2019s disease: minding the store. Aging Cell 6(3):307\u2013317","journal-title":"Aging Cell"},{"issue":"4","key":"1634_CR65","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.bbrc.2003.12.034","volume":"313","author":"Y Takano","year":"2004","unstructured":"Takano Y, Ohguro H, Dezawa M, Ishikawa H, Yamazaki H, Ohguro I et al (2004) Study of drug effects of calcium channel blockers on retinal degeneration of rd mouse. Biochem Biophys Res Commun 313(4):1015\u20131022","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1634_CR66","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.matpr.2017.11.295","volume":"5","author":"J Krishnan","year":"2018","unstructured":"Krishnan J, Malathi R (2018) Effect of L, T and N-Type Calcium channels on retinal ganglion cells. Mater Today Proc 5(1):1929\u20131935","journal-title":"Mater Today Proc"},{"issue":"1","key":"1634_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5005\/jp-journals-10008-1155","volume":"8","author":"S Ganekal","year":"2014","unstructured":"Ganekal S, Dorairaj S, Jhanji V, Kudlu K (2014) Effect of topical calcium channel blockers on intraocular pressure in steroid-induced glaucoma. J Curr Glaucoma Pract 8(1):15","journal-title":"J Curr Glaucoma Pract"},{"issue":"1","key":"1634_CR68","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.preteyeres.2010.09.002","volume":"30","author":"M Araie","year":"2011","unstructured":"Araie M, Mayama C (2011) Use of calcium channel blockers for glaucoma. Prog Retin Eye Res 30(1):54\u201371","journal-title":"Prog Retin Eye Res"},{"issue":"13","key":"1634_CR69","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1016\/j.bmcl.2012.04.130","volume":"22","author":"D Luo","year":"2012","unstructured":"Luo D, Fan Y, Xu X (2012) The effects of aminoguanidine on retinopathy in STZ-induced diabetic rats. Bioorg Med Chem Lett 22(13):4386\u20134390","journal-title":"Bioorg Med Chem Lett"},{"issue":"17","key":"1634_CR70","doi-asserted-by":"publisher","first-page":"9944","DOI":"10.1073\/pnas.96.17.9944","volume":"96","author":"AH Neufeld","year":"1999","unstructured":"Neufeld AH, Sawada A, Becker B (1999) Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci 96(17):9944\u20139948","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"1634_CR71","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1167\/iovs.09-4995","volume":"51","author":"B Falsini","year":"2010","unstructured":"Falsini B, Piccardi M, Minnella A, Savastano C, Capoluongo E, Fadda A et al (2010) Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Invest Ophthalmol Vis Sci 51(12):6118\u20136124","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1634_CR72","first-page":"196","volume":"11","author":"A Riazi","year":"2017","unstructured":"Riazi A, Panahi Y, Alishiri AA, Hosseini MA, Zarchi AAK, Sahebkar A (2017) The impact of saffron (Crocus sativus) supplementation on visual function in patients with dry age-related macular degeneration. Ital J Med 11(2):196\u2013201","journal-title":"Ital J Med"},{"issue":"7","key":"1634_CR73","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/antiox8070224","volume":"8","author":"S Di Marco","year":"2019","unstructured":"Di Marco S, Carnicelli V, Franceschini N, Di Paolo M, Piccardi M, Bisti S et al (2019) Saffron: a multitask neuroprotective agent for retinal degenerative diseases. Antioxidants 8(7):224","journal-title":"Antioxidants"},{"issue":"3","key":"1634_CR74","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4103\/0975-7406.84471","volume":"3","author":"R Saini","year":"2011","unstructured":"Saini R (2011) Coenzyme Q10: the essential nutrient. J Pharm Bioallied Sci 3(3):466\u2013467","journal-title":"J Pharm Bioallied Sci"},{"key":"1634_CR75","first-page":"597","volume":"5","author":"M Spindler","year":"2009","unstructured":"Spindler M, Beal MF, Henchcliffe C (2009) Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatr Dis Treat 5:597","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"1634_CR76","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.nbd.2004.10.021","volume":"18","author":"M Somayajulu","year":"2005","unstructured":"Somayajulu M, McCarthy S, Hung M, Sikorska M, Borowy-Borowski H, Pandey S (2005) Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10. Neurobiol Dis 18(3):618\u2013627","journal-title":"Neurobiol Dis"},{"issue":"1\u20134","key":"1634_CR77","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/biof.5520320121","volume":"32","author":"C Schmelzer","year":"2008","unstructured":"Schmelzer C, Lindner I, Rimbach G, Niklowitz P, Menke T, D\u00f6ring F (2008) Functions of coenzyme Q10 in inflammation and gene expression. BioFactors 32(1\u20134):179\u2013183","journal-title":"BioFactors"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-020-01634-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-020-01634-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-020-01634-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T16:04:01Z","timestamp":1615305841000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-020-01634-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1634"],"URL":"https:\/\/doi.org\/10.1007\/s10792-020-01634-8","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"type":"print","value":"0165-5701"},{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"assertion":[{"value":"20 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}